||Molecular Cancer Therapeutics (ISSN: 1535-7163, ESSN: 1538-8514)
||This is a RoMEO white journal|
||A paid open access option is available for this journal.
|| archiving status unclear|
|| subject to Restrictions below, author can archive post-print (ie final draft post-refereeing)|
|| author cannot archive publisher's version/PDF|
- NIH authors may post authors' own version in PubMed Central for release 12 months after publication
- HHMI, Wellcome Trust, Cancer Research UK and UK Medical Research Council authors may deposit authors own version in Europe PMC for release 6 months after publication
- AACR will deposit on behalf of these authors, if required
- Authors final version may be deposited on institutional website or institutional repository if required by institution
- Published source must be acknowledged
- Must link to the publisher PDF of article on journal website
|Paid Open Access:
||06-Jun-2013 - Suggest an update for this record|
|Link to this page:
This summary is for the journal's default policies, and changes or exceptions can often be negotiated by authors.
All information is correct to the best of our knowledge but should not be relied upon for legal advice.